封面
市場調查報告書
商品編碼
1424861

全球骨移植/人造骨市場 - 市場規模(按細分市場)、份額、監管、報銷、治療、預測(~2033 年)

Bone Grafts and Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

骨移植物和人工骨廣泛應用於骨科手術中,用途廣泛。 由於骨骼衰弱而遭受骨科併發症的患者數量不斷增加,預計需求將受到推動。 隨著更容易患骨科疾病的老化人口的增加,預計骨科手術的數量也會增加。 因此,預計在預測期內會有很高的需求。

本報告研究和分析了全球骨移植/人造骨市場,並提供了有關每個細分市場的市場規模、市場趨勢、競爭狀況以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

市售骨移植和人造骨裝置以及不斷變化的競爭格局

  • 對主要產業趨勢的考慮
  • 按骨移植/人造骨裝置市場細分的年收入和市場前景(2015-2033 年)
  • 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

  • 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
  • 骨移植物和人工骨裝置的SWOT分析
  • 骨移植/人造骨裝置市場競爭動態的思考與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息,使您能夠更深入地研究市場動態。

  • 各國醫療保健系統概覽
  • 按國家/地區劃分的報銷政策
  • 各國醫療科技監理狀況

目標公司

  • Medtronic Plc
  • Globus Medical Inc
  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • Bioventus Inc
  • 其他

Bone Grafts and Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Bone Grafts & Substitutes Devices market for the year 2020 and beyond. Bone grafts & substitutes are extensively used in orthopedic surgeries for several applications. Increasing cases of orthopedic complications caused due to weakened bones are projected to fuel demand. The number of orthopedic surgeries is anticipated to grow with intensifying geriatric population susceptible to orthopedic sicknesses. Thus, the market is anticipated to witness significant demand during the forecast period.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Bone Grafts & Substitutes Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Bone Grafts & Substitutes Devices market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Bone Grafts & Substitutes Devices.
  • Competitive dynamics insights and trends provided for Bone Grafts & Substitutes Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Medtronic Plc, Globus Medical Inc, Stryker Corp, Zimmer Biomet Holdings Inc, Bioventus Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Bone Grafts and Substitutes marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Bone Grafts & Substitutes market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Bone Grafts & Substitutes market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Bone Grafts & Substitutes market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Bone Grafts & Substitutes market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable